Post-authorisation safety study of the incidence rate of medication errors before and after the discontinuation of the lower strength vials for Pharmalgen (NI-PH-X-01)

First published 21/09/2018

Last updated 02/07/2024

EU PAS number:

EUPAS25639

Study

Finalised

Documents

Study protocol

Initial protocol

PASS protocol Pharmalgen_final

English (710.18 KB - PDF) View document

Study results

Pharmalgen PASS summary_final

English (24.84 KB - PDF) View document

Study report

Other information

Secondary tabs